Acute Raspberry Intake on Metabolic Control and Cognitive Function
The Effects of Acute Raspberry Intake on the Relationship Between Enhanced Metabolic Control and Cognitive and Psychomotor Function
1 other identifier
interventional
6
1 country
1
Brief Summary
The purpose of this project is to determine whether restoring the post-prandial metabolic/inflammatory balance via supplementation with raspberries results in improved cognitive performance, and if these enhancements are mediated through improvements in vascular function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 7, 2018
CompletedFirst Posted
Study publicly available on registry
November 16, 2018
CompletedStudy Start
First participant enrolled
February 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2023
CompletedMay 10, 2023
May 1, 2023
2.7 years
November 7, 2018
May 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychomotor function
Psychomotor function will be measured with the Grooved Pegboard
Baseline to 6 hours
Secondary Outcomes (1)
Endothelial function
Baseline to 5 hours
Study Arms (2)
Active
EXPERIMENTALFreeze-dried red raspberry powder (25 g) in active breakfast meal
Placebo
PLACEBO COMPARATORPlacebo breakfast
Interventions
freeze-dried red raspberry powder (12.5 g) in drink+ freeze-dried red raspberry powder (12.5 g) in buttermilk biscuit sandwich
Eligibility Criteria
You may qualify if:
- BMI between 27 and 35 kg/m2 and/or waist circumference (\>35 inches for women, \>40 inches for men)
- Aged 55-70 years old
- Able to provide informed consent and comply with study procedures
- Willing to maintain stable body weight and follow his/her habitual diet and physical activity patterns throughout the trial.
- Judged by the Investigator to be in general good health on the basis of medical history and screening laboratory tests.
You may not qualify if:
- Current smoker and/or marijuana user, past smokers may be allowed in the study if stopped \>2 years
- Have a history or presence of atherosclerotic cardiovascular disease, inflammatory disease, diabetes mellitus, or other systemic diseases, psychological or psychiatric disorders
- Have recent surgery or injury to head
- Mini-Mental Status Exam score \< 24 or Beck Depression Inventory score \> 20
- Taking any medications that would interfere with outcomes of the study (i.e., lipid- lowering medications, anti-inflammatory drugs, and supplements, not including multivitamin/mineral or calcium/Vit D supplements),
- Unstable use of any medication/supplement
- Have a history of cancer in the prior 5 years, except for non-melanoma skin cancer
- Addicted to drugs and/or alcohol (\>2 drinks/day)
- Have been exposed to any non-registered drug product within last 30 days.
- Working overnight (e.g. 3rd shift of overnight workers)
- Excessive exercisers or trained athletes
- Have allergies/intolerances to berries.
- Vegetarian/vegan or have extreme dietary habits.
- Excessive coffee/tea drinker
- Actively losing weight/ trying to lose weight (unstable body weight fluctuations of \> 5 kg in 3 months)
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USDA Human Nutrition Research Center on Aging
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Barbara Shukitt-Hale, PhD
USDA Human Nutrition Research Center on Aging
- PRINCIPAL INVESTIGATOR
Tammy M Scott, PhD
Tufts University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2018
First Posted
November 16, 2018
Study Start
February 1, 2019
Primary Completion
October 1, 2021
Study Completion
April 30, 2023
Last Updated
May 10, 2023
Record last verified: 2023-05
Data Sharing
- IPD Sharing
- Will not share